NewMarket (NEU) Fundamental Analysis: Bull vs. Bear Case

NEU

NewMarket

Fundamental data last updated:April 13, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Basic Materials

industry

Specialty Chemicals

Exchange

NYSE

County of HQ

United States

Next Earnings Date

04/22/26

Business Summary

NewMarket operates in specialty chemical niches where formulations and additive technologies are embedded into customers’ end products, creating switching costs and repeat demand. The company generates cash by producing high-margin chemical solutions that enhance performance characteristics, allowing it to sustain a 23.50% operating margin in a materials business. Its moat likely stems from technical expertise, long-standing customer relationships, and the high cost of reformulating chemical inputs once validated. With 16.90% ROIC and modest leverage at 20.00% debt/equity, it converts that moat into durable free cash generation rather than balance sheet risk.

VALUATION

P/E

14.1 Market Cap ($M USD)

$5,907

Forward P/E

-

PEG

-

PRICE TO SALES

2.2 PRICE TO BOOK

3.3 EV / EBITDA

9.4 5-Year Average P/E

Free Cash Flow Yield

DCF Value

Graham Number

Price to FCF

EV to FCF

Earnings Yield

FCF Yield

DIVIDEND

Yield

1.80%

Annual Payout

$11.50

Payout Ratio

25.30%

Consecutive Years of Dividend Growth

7 5-Year Dividend Growth Rate

9.60%

Financial Health & Profitability

Earnings Per Share

$44.44

Next Year EPS Growth Estimate

-

Next Year Revenue Growth Estimate

-

Return on Equity (ROE)

23.50%

FREE CASH FLOW

Operating Margin

20.00%

Debt-to-Equity

0.6 Piotroski F-Score

5 Altman Z-Score

4.3 Return on Invested Capital (ROIC)

16.90%

Current Ratio

2.5 Quick Ratio

Net Debt to EBITDA

Interest Coverage

Gross Profit margin

FCF PER SHARE

REVENUE PER SHARE

Gainseekers Quantitative Analysis

Summary

At 14.1x earnings with a 4.3 Altman Z-Score and 16.90% ROIC, this is not a distressed cyclical—it’s a financially stable compounder trading at a market multiple despite specialty chemical economics. The balance sheet is clearly solid with a 2.5 current ratio and only 20.00% debt/equity, which materially lowers insolvency risk. The absence of a Forward P/E and PEG makes growth visibility opaque, but the combination of 23.50% operating margins and strong capital efficiency suggests the market may be underpricing durability rather than overpricing growth. This looks more like a conservatively valued cash generator than a speculative materials name.

AI Exposure / Tech Reliance

As a Specialty Chemicals company, NewMarket operates in a formulation-driven industry where process optimization, additive chemistry, and performance enhancement are increasingly data-driven. AI and advanced modeling can accelerate R&D efficiency and improve product customization, which benefits incumbents with scale and margin discipline. Given its 23.50% operating margin, it appears structurally positioned to absorb technological upgrades without margin compression.

The Bull Case

A GARP or deep value investor buys this because the capital efficiency is real: 16.90% ROIC in Basic Materials is elite, and it’s being acquired at just 14.1x earnings. The 23.50% operating margin signals pricing power and product differentiation, not commodity exposure. Financial stability is reinforced by a 4.3 Altman Z-Score and 2.5 current ratio, while the Piotroski F-Score of 5 indicates operational stability rather than deterioration. Add a 0.6 yield with a 7% 5-year average dividend growth rate, and you have a conservatively financed compounder with institutional-quality economics hiding in a cyclical sector wrapper.

The Bear Case

The red flags are subtle but real. Short interest at 9.60% of float is elevated enough to suggest skepticism around sustainability of earnings or forward growth visibility. The lack of Forward P/E, PEG Forward, Sales Growth Next Year, ROE, and institutional ownership data makes forward underwriting difficult, and the Piotroski F-Score of 5 is middling rather than strong. The payout ratio listed at $11.50 is inconsistent with the 0.6 yield and introduces ambiguity around capital allocation discipline, which in a cyclical sector can become a problem quickly if margins revert.

Market Sentiment & Smart Money

Short Interest %

8.20%

Analyst Consensus

-

Average Analyst Price Target

-

Institutional Ownership %

68.90%

1-Year Beta

0.62 Insider Buying % (6 Mo)

18.80%%

Distance to 52-Week High

71.80%

Distance to 52-Week Low

114.90%

EARNINGS SURPRISE %

50-DAY SMA

200-DAY SMA

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.